British Journal of Ophthalmology · 1989 · 13 citations · 2 references
Life SciencesDevelopmental BiologyImmunologyDevelopmental ImmunologyGene ExpressionImmunoregulationMicrorna BiogenesisMicrorna BiologyMicrorna-mediated RegulationNoncoding Rna In CancerRna InterferenceMicrorna In DevelopmentMicrorna In Immune RegulationMicrorna Regulation In DevelopmentMicrorna Regulation Of DifferentiationMicrorna-mediated Immune RegulationRegulatorsThymic T Cell DevelopmentTranslational Regulation By Micrornas
CD1d-restricted invariant natural killer T (iNKT) cells play an important role in the regulation of diverse immune responses. MicroRNAs (miRNAs), a class of 21-25 nt single-stranded non-coding small RNAs, are increasingly being recognized as important regulators of gene expression through the inhibition of effective mRNA translation. We recently reported that miRNAs expressed in iNKT cell lineage are potent regulators of iNKT cell development, maturation, and function. However, the role of specific miRNAs in the iNKT cells has not been addressed so far. Using miRNA arrays, we found that the expression of miR-150 was significantly upregulated in mature iNKT cells compared to immature iNKT cells in the thymus. Interestingly, mice with miR-150 deficiency have a defect in iNKT cell development in the thymus and iNKT cell maturation was blocked at developmental stage 1 and 2, while the peripheral iNKT cells maturated normally. Furthermore, miR-150-deficient peripheral iNKT cells produce more cytokine interferon-gamma compared to that from wild type after PMA/Ionomycin stimulation. Thus, our results suggest that miR-150 controls iNKT cell thymic maturation and regulates iNKT cell function.
2
Superior vena caval obstruction syndrome in small cell lung cancer
Jean Paul Sculier, William K. Evans, Ronald Feld et al. · Cancer · 1986 · 92 citations
Carcinoma metastatic to the anterior ocular segment: Response to chemotherapy
John S. Sierocki, Norman C. Charles, Michael Schafrank et al. · Cancer · 1980 · 18 citations · Full text
Medicine, Oncology, Ophthalmology +17